She also emphasized that the two-dose schedule is not yet approved in the U.S. Economically, of course it’s going to be cheaper.” “Will the FDA go for a two-dose schedule? There are a number of countries that say they approve, but not all of them have started using it.

“You want to extrapolate and say, what’s going to happen to 25-year-olds?” she said.